UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021495
Receipt number R000024747
Scientific Title Effect and safety of Diphteria-Pertussis-Tetanus vaccine among healthcare workers
Date of disclosure of the study information 2016/03/16
Last modified on 2017/11/18 07:42:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect and safety of Diphteria-Pertussis-Tetanus vaccine among healthcare workers

Acronym

Effect and safety of DTaP among healthcare workers

Scientific Title

Effect and safety of Diphteria-Pertussis-Tetanus vaccine among healthcare workers

Scientific Title:Acronym

Effect and safety of DTaP among healthcare workers

Region

Japan


Condition

Condition

Pertussis

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Pertussis is epidemic throughout the world in young adults. Tdap has been used in many countries and is proved to be effective for elevation levels of antibody to Pertussis. Since it takes so many years to obtain the license of new vaccine in Japan, we have no other option but to use DTaP alternatively. There are few studies which examined the usefulness and effectiveness of DTaP administered to adults. Moreover no study had ever discussed the duration of effectiveness. In this study we monitored Pertussis titers of healthcare workers who provide medical care to children by examined antibodies against PT, FHA, Fim2, Fim3, catACT and cFHA.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We measure antibodies against PT, FHA, Fim2, Fim3, catACT and cFHA using enzyme-linked immunosorbent assay before vaccination, one month and one year after vaccination.

Key secondary outcomes

We carry out a questionnaire survey to examine the safety of vaccination within seven days after administration about the presence of fever, headache, malaise, pain, redness, swelling and sensations of burning.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Vaccine

Interventions/Control_1

We examine the study from January 1st, 2014 to January 31th, 2015. We measure antibodies against Pertussis antigen in the eligible person who obtained our consent, thereafter we vaccinate with DTaP which are reduced from 0.5mL to 0.2mL.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

- Healthcare worker who work in hospital ward and outpatient department at Children's Medical Center and Perinatal Center, Yokohama City University Medical Center.
- Eligible person who obtained our consent.
- Age over the 20 years old and under the 65 years old.

Key exclusion criteria

- Healthcare worker who had a history of serious side effect from vaccination.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Shimizu

Organization

Yokohama City University Medical Center

Division name

Children's Medical Center

Zip code


Address

4-57, Urafune-cho, Minami-ku, Yokohama-shi, Kanagawa, Japana

TEL

045-261-5656

Email

hiroyukiowl@hotmail.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Shimizu

Organization

Yokohama City University Medical Center

Division name

Children's Medical Center

Zip code


Address

4-57, Urafune-cho, Minami-ku, Yokohama-shi, Kanagawa, Japana

TEL

045-261-5656

Homepage URL


Email

hiroyukiowl@hotmail.co.jp


Sponsor or person

Institute

Yokohama City University Medical Center

Institute

Department

Personal name



Funding Source

Organization

Yokohama City University Medical Center
Children's Medical Center
Perinatal Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kitasato Institute for Life Sciences

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜市立大学附属市民総合医療センター


Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 16 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 03 Month 02 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 02 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 03 Month 16 Day

Last modified on

2017 Year 11 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024747


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name